Ikarian Capital, LLC - CATABASIS PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of CATABASIS PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2021$1,124,000
-54.4%
532,298
-37.6%
0.09%
+9.6%
Q1 2021$2,464,000
+77.0%
852,998
+31.2%
0.08%
+36.1%
Q4 2020$1,392,000650,0000.06%
Other shareholders
CATABASIS PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 300,000$2,421,0001.60%
SV Health Investors, LLC 285,765$2,306,0001.55%
Alyeska Investment Group, L.P. 1,125,000$9,079,0000.12%
FEDERATED HERMES, INC. 2,189,400$17,668,0000.04%
OXFORD ASSET MANAGEMENT LLP 139,451$1,125,0000.02%
OPPENHEIMER & CO INC 68,706$554,0000.02%
RMB Capital Management, LLC 60,618$489,0000.01%
Blackstone Inc. 200,819$1,621,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 20,900$169,0000.00%
DIMENSIONAL FUND ADVISORS LP 218,651$1,765,0000.00%
View complete list of CATABASIS PHARMACEUTICALS IN shareholders